Boundless Bio
inhibition of kinase is synthetic lethal in cancer cells is a master regulator of the response | Boundless Bio
Company
Deck Type
IPO
Sector
Industry
Deck date
March 2024
Slide
27 of 51
Related slides by other companies
Exscientia
Investor Presentation
March 2024
inhibition drives to quiescence oes | Exscientia
Compass Therapeutics
Investor Presentation
May 2023
partial response in a patient with small cell lung cancer i | Compass Therapeutics
Exscientia
Investor Presentation
November 2023
inhibition drives to quiescence | Exscientia
Mink Therapeutics
Investor Day
November 2022
| Mink Therapeutics
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io